# pathway_0107: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0107.txt)

**Task:** `pathway`  
**Author key, unchanged:** **A** — Lipid metabolism. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | uncertain | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MKDLFEHIYANKGSIGRWSDHAEGYYVFPKLEGELGPHMKFQGKEILNWSINDYLGLANHPEVRKVDAEAAAEYGAAYPMGARMMSGHTTMHEELEKRLAKFVHKEASYLLNFGYQGMVSIIDALVTKNDVIVYDVDAHACIIDGVRLHFGKRYTYQHNDMESFEKNLERAAKLAETTGGGILVISEGVFGMRGEQGKLKEIVALKKKYPFRLLVDDAHGFGTLGPRGEGTGVHQGVQDEIDVYFSTFAKSMAGIGAFVAGNAKVVDYLKYNLRSQMFAKSLPMIYVKGALKRLEMMETMPELQQKLWDNVNRLQNGLKERGFNIGNTNTCVTPVFLHGSIPEAMAMVNDLREHYGIFLSIVVYPVIPKGMILLRIIPTASHSKEDIDRTLEAFSAIREKLETGVYRAINAELTKEMGDM

[Multiple Choices]
A. Lipid metabolism. .
B. Carbohydrate degradation
C. terpenoid biosynthesis. .
D. L-histidine from 5-phospho-alpha-D-ribose 1-diphosphate: step 4/9. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches a UniProt entry annotated as cysteate-C-fatty acyltransferase, with its pathway listed as lipid metabolism. The annotation cites a 2022 study on capnine biosynthesis, supporting choice A for this protein.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is a soluble enzyme-like protein, but the supplied sequence and choices do not provide a specific, reliable clue that identifies its substrate or pathway.


**Missing item-specific fact**

> The protein-specific function—cysteate-C-fatty acyltransferase in lipid metabolism—is needed to distinguish choice A.


**Reason**

> Choosing the annotated pathway depends on knowing this protein’s identity or experimentally characterized function; recognizing the exact sequence or relying on generic sequence heuristics would not constitute reasoning from the supplied input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched-sequence pathway annotation supports lipid metabolism; the other options are not supported by the supplied sequence-level evidence.


### Important caveats

- The pathway annotation is a database assertion citing a publication, not itself a direct experimental measurement.
- The actual author source snapshot is unknown, although the sequence matches both the archived and current entries.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is a soluble enzyme-like protein, but the supplied sequence and choices do not provide a specific, reliable clue that identifies its substrate or pathway.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific function—cysteate-C-fatty acyltransferase in lipid metabolism—is needed to distinguish choice A.",
    "reason": "Choosing the annotated pathway depends on knowing this protein’s identity or experimentally characterized function; recognizing the exact sequence or relying on generic sequence heuristics would not constitute reasoning from the supplied input."
  },
  "case_id": "pathway_0107",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated as cysteate-C-fatty acyltransferase, with its pathway listed as lipid metabolism. The annotation cites a 2022 study on capnine biosynthesis, supporting choice A for this protein."
  },
  "important_caveats": [
    "The pathway annotation is a database assertion citing a publication, not itself a direct experimental measurement.",
    "The actual author source snapshot is unknown, although the sequence matches both the archived and current entries."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched-sequence pathway annotation supports lipid metabolism; the other options are not supported by the supplied sequence-level evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0107",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt entry annotated as cysteate-C-fatty acyltransferase, with its pathway listed as lipid metabolism. The annotation cites a 2022 study on capnine biosynthesis, supporting choice A for this protein.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is a soluble enzyme-like protein, but the supplied sequence and choices do not provide a specific, reliable clue that identifies its substrate or pathway.",
    "missing_item_specific_fact": "The protein-specific function—cysteate-C-fatty acyltransferase in lipid metabolism—is needed to distinguish choice A.",
    "reason": "Choosing the annotated pathway depends on knowing this protein’s identity or experimentally characterized function; recognizing the exact sequence or relying on generic sequence heuristics would not constitute reasoning from the supplied input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched-sequence pathway annotation supports lipid metabolism; the other options are not supported by the supplied sequence-level evidence."
  },
  "important_caveats": [
    "The pathway annotation is a database assertion citing a publication, not itself a direct experimental measurement.",
    "The actual author source snapshot is unknown, although the sequence matches both the archived and current entries."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotation for C7M8J6 (Cysteate-C-fatty acyltransferase, EC 2.3.1.-) explicitly lists 'PATHWAY: Lipid metabolism' (evidence code ECO:0000305, PubMed:35414181). The protein catalyzes fatty acyl transfer in sulfonolipid capnine biosynthesis, confirmed experimentally in the 2022 Biochemistry paper by Liu et al. The EC class 2.3.1 (acyltransferases) and the fatty-acyl transfer reaction are consistent with lipid metabolism.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains motifs loosely resembling acyltransferase domains (e.g., the 'GGILVISEGVFGMRGEQGKLKEIVALKKK' region), which could weakly suggest transferase activity. However, acyltransferases participate in many pathways (amino acid modification, secondary metabolism, lipid metabolism), so this alone does not uniquely point to 'Lipid metabolism' over the other three choices. Eliminating carbohydrate degradation, terpenoid biosynthesis, and histidine biosynthesis requires knowing this is specifically a cysteate-C-fatty acyltransferase in the sulfonolipid capnine biosynthetic pathway.


**Missing item-specific fact**

> The specific identity of this protein as Cysteate-C-fatty acyltransferase (CapB) in the sulfonolipid capnine biosynthetic pathway of Capnocytophaga ochracea, and its UniProt pathway assignment to 'Lipid metabolism.' This is a highly specialized, recently characterized enzyme (Swiss-Prot entry first public 2025-04-09) whose pathway annotation rests on a single 2022 experimental study.


**Reason**

> While the sequence has faint acyltransferase-like features, the leap from 'possibly an acyltransferase' to the broad pathway category 'Lipid metabolism' (as opposed to, say, amino acid metabolism or secondary metabolite biosynthesis) requires the specific item-level knowledge that this enzyme transfers a fatty acyl group onto cysteate to build a sulfonolipid. Without recognizing the exact protein or having prior knowledge of capnine biosynthesis, general sequence reasoning cannot reliably distinguish option A from B, C, or D.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options span distinct metabolic categories (lipid, carbohydrate, terpenoid, amino acid biosynthesis). Given the correct protein identity, only 'Lipid metabolism' is defensible. No ambiguity among options once the protein is identified.


### Important caveats

- The UniProt Swiss-Prot entry for C7M8J6 was first publicly released on 2025-04-09, making it very recent. The pathway annotation (ECO:0000305) indicates it was curated based on the 2022 experimental paper rather than being an inferred or transferred annotation.
- The EC number is incomplete (2.3.1.-), indicating the exact substrate specificity classification is still being refined.
- Sulfonolipid biosynthesis is a niche pathway primarily studied in Capnocytophaga and a few other Bacteroidota; the broad 'Lipid metabolism' UniProt pathway label may not be intuitive from sequence alone.
- The reviewer-only evidence confirms sequence match (SHA-256 identical, 420 AA) between the benchmark sequence and the UniProt entry, so the annotation applies to the exact sequence presented.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains motifs loosely resembling acyltransferase domains (e.g., the 'GGILVISEGVFGMRGEQGKLKEIVALKKK' region), which could weakly suggest transferase activity. However, acyltransferases participate in many pathways (amino acid modification, secondary metabolism, lipid metabolism), so this alone does not uniquely point to 'Lipid metabolism' over the other three choices. Eliminating carbohydrate degradation, terpenoid biosynthesis, and histidine biosynthesis requires knowing this is specifically a cysteate-C-fatty acyltransferase in the sulfonolipid capnine biosynthetic pathway.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific identity of this protein as Cysteate-C-fatty acyltransferase (CapB) in the sulfonolipid capnine biosynthetic pathway of Capnocytophaga ochracea, and its UniProt pathway assignment to 'Lipid metabolism.' This is a highly specialized, recently characterized enzyme (Swiss-Prot entry first public 2025-04-09) whose pathway annotation rests on a single 2022 experimental study.",
    "reason": "While the sequence has faint acyltransferase-like features, the leap from 'possibly an acyltransferase' to the broad pathway category 'Lipid metabolism' (as opposed to, say, amino acid metabolism or secondary metabolite biosynthesis) requires the specific item-level knowledge that this enzyme transfers a fatty acyl group onto cysteate to build a sulfonolipid. Without recognizing the exact protein or having prior knowledge of capnine biosynthesis, general sequence reasoning cannot reliably distinguish option A from B, C, or D."
  },
  "case_id": "pathway_0107",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt annotation for C7M8J6 (Cysteate-C-fatty acyltransferase, EC 2.3.1.-) explicitly lists 'PATHWAY: Lipid metabolism' (evidence code ECO:0000305, PubMed:35414181). The protein catalyzes fatty acyl transfer in sulfonolipid capnine biosynthesis, confirmed experimentally in the 2022 Biochemistry paper by Liu et al. The EC class 2.3.1 (acyltransferases) and the fatty-acyl transfer reaction are consistent with lipid metabolism."
  },
  "important_caveats": [
    "The UniProt Swiss-Prot entry for C7M8J6 was first publicly released on 2025-04-09, making it very recent. The pathway annotation (ECO:0000305) indicates it was curated based on the 2022 experimental paper rather than being an inferred or transferred annotation.",
    "The EC number is incomplete (2.3.1.-), indicating the exact substrate specificity classification is still being refined.",
    "Sulfonolipid biosynthesis is a niche pathway primarily studied in Capnocytophaga and a few other Bacteroidota; the broad 'Lipid metabolism' UniProt pathway label may not be intuitive from sequence alone.",
    "The reviewer-only evidence confirms sequence match (SHA-256 identical, 420 AA) between the benchmark sequence and the UniProt entry, so the annotation applies to the exact sequence presented."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span distinct metabolic categories (lipid, carbohydrate, terpenoid, amino acid biosynthesis). Given the correct protein identity, only 'Lipid metabolism' is defensible. No ambiguity among options once the protein is identified."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0107",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotation for C7M8J6 (Cysteate-C-fatty acyltransferase, EC 2.3.1.-) explicitly lists 'PATHWAY: Lipid metabolism' (evidence code ECO:0000305, PubMed:35414181). The protein catalyzes fatty acyl transfer in sulfonolipid capnine biosynthesis, confirmed experimentally in the 2022 Biochemistry paper by Liu et al. The EC class 2.3.1 (acyltransferases) and the fatty-acyl transfer reaction are consistent with lipid metabolism.",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains motifs loosely resembling acyltransferase domains (e.g., the 'GGILVISEGVFGMRGEQGKLKEIVALKKK' region), which could weakly suggest transferase activity. However, acyltransferases participate in many pathways (amino acid modification, secondary metabolism, lipid metabolism), so this alone does not uniquely point to 'Lipid metabolism' over the other three choices. Eliminating carbohydrate degradation, terpenoid biosynthesis, and histidine biosynthesis requires knowing this is specifically a cysteate-C-fatty acyltransferase in the sulfonolipid capnine biosynthetic pathway.",
    "missing_item_specific_fact": "The specific identity of this protein as Cysteate-C-fatty acyltransferase (CapB) in the sulfonolipid capnine biosynthetic pathway of Capnocytophaga ochracea, and its UniProt pathway assignment to 'Lipid metabolism.' This is a highly specialized, recently characterized enzyme (Swiss-Prot entry first public 2025-04-09) whose pathway annotation rests on a single 2022 experimental study.",
    "reason": "While the sequence has faint acyltransferase-like features, the leap from 'possibly an acyltransferase' to the broad pathway category 'Lipid metabolism' (as opposed to, say, amino acid metabolism or secondary metabolite biosynthesis) requires the specific item-level knowledge that this enzyme transfers a fatty acyl group onto cysteate to build a sulfonolipid. Without recognizing the exact protein or having prior knowledge of capnine biosynthesis, general sequence reasoning cannot reliably distinguish option A from B, C, or D."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span distinct metabolic categories (lipid, carbohydrate, terpenoid, amino acid biosynthesis). Given the correct protein identity, only 'Lipid metabolism' is defensible. No ambiguity among options once the protein is identified."
  },
  "important_caveats": [
    "The UniProt Swiss-Prot entry for C7M8J6 was first publicly released on 2025-04-09, making it very recent. The pathway annotation (ECO:0000305) indicates it was curated based on the 2022 experimental paper rather than being an inferred or transferred annotation.",
    "The EC number is incomplete (2.3.1.-), indicating the exact substrate specificity classification is still being refined.",
    "Sulfonolipid biosynthesis is a niche pathway primarily studied in Capnocytophaga and a few other Bacteroidota; the broad 'Lipid metabolism' UniProt pathway label may not be intuitive from sequence alone.",
    "The reviewer-only evidence confirms sequence match (SHA-256 identical, 420 AA) between the benchmark sequence and the UniProt entry, so the annotation applies to the exact sequence presented."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record annotates the protein as a cysteate-C-fatty acyltransferase and assigns it to lipid metabolism. This supports choice A, although the supplied excerpts do not independently validate the underlying study's experiments.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6).

### Reasoning versus lookup: uncertain

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The sequence is compatible with an enzyme, but no pathway-specific feature is evident from the supplied input alone. A family-level or homolog-based inference might distinguish the choices, but the available evidence does not establish such an inference; the reviewer-only annotation cannot be treated as input to the model.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The sequence-matched source assigns the protein to lipid metabolism; no other offered choice is supported by the supplied evidence.


### Important caveats

- The pathway assignment is a database annotation citing a publication, not an experimental result reproduced in the excerpts.
- The reviewer-only source identity and annotations were absent from the original inputs.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "cannot_determine",
    "missing_item_specific_fact": "",
    "reason": "The sequence is compatible with an enzyme, but no pathway-specific feature is evident from the supplied input alone. A family-level or homolog-based inference might distinguish the choices, but the available evidence does not establish such an inference; the reviewer-only annotation cannot be treated as input to the model."
  },
  "case_id": "pathway_0107",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the protein as a cysteate-C-fatty acyltransferase and assigns it to lipid metabolism. This supports choice A, although the supplied excerpts do not independently validate the underlying study's experiments."
  },
  "important_caveats": [
    "The pathway assignment is a database annotation citing a publication, not an experimental result reproduced in the excerpts.",
    "The reviewer-only source identity and annotations were absent from the original inputs."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-matched source assigns the protein to lipid metabolism; no other offered choice is supported by the supplied evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0107",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates the protein as a cysteate-C-fatty acyltransferase and assigns it to lipid metabolism. This supports choice A, although the supplied excerpts do not independently validate the underlying study's experiments.",
    "evidence_ids": ["C4", "C5", "C6"]
  },
  "answerability_check": {
    "judgment": "cannot_determine",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "",
    "reason": "The sequence is compatible with an enzyme, but no pathway-specific feature is evident from the supplied input alone. A family-level or homolog-based inference might distinguish the choices, but the available evidence does not establish such an inference; the reviewer-only annotation cannot be treated as input to the model."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-matched source assigns the protein to lipid metabolism; no other offered choice is supported by the supplied evidence."
  },
  "important_caveats": [
    "The pathway assignment is a database annotation citing a publication, not an experimental result reproduced in the excerpts.",
    "The reviewer-only source identity and annotations were absent from the original inputs."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry (C7M8J6) annotates the pathway as 'Lipid metabolism' with evidence code ECO:0000305 linked to PubMed:35414181 (the capnine sulfonolipid biosynthesis paper). The protein is named 'Cysteate-C-fatty acyltransferase' (EC 2.3.1.-), catalyzing the transfer of a fatty acyl group to cysteate—a lipid biosynthesis reaction. The pathway annotation is directly supported by experimental characterization of the capnine biosynthetic pathway.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The three distractor options (B: carbohydrate degradation, C: terpenoid biosynthesis, D: histidine biosynthesis step 4/9) correspond to enzyme families with well-characterized and distinctive sequence signatures. Carbohydrate-degrading enzymes (glycosidases, cellulases, amylases) possess specific catalytic motifs (e.g., WWDYG for GH families, specific TIM-barrel or β-sandwich folds). Terpenoid biosynthesis enzymes (terpene cyclases, prenyltransferases) display diagnostic DDXXD, NDXXD, or GxGxxG prenyltransferase motifs and characteristic folds. Histidine biosynthesis enzymes (HisA through HisI) each have distinct, well-known domain architectures (e.g., HisA is a TIM-barrel phosphoribosyl-ATP pyrophosphohydrolase; HisB is a phosphatase). The supplied 420-aa sequence lacks all of these signatures. By elimination, lipid metabolism (option A) remains. Additionally, the sequence contains GxG-type motifs (e.g., 'GFGTLGPRGEGTGVHQGVQDEIDVYFSTFAKSMAGIGAFVAGNAKVVDYLKY') and an overall fold consistent with acyltransferase/thioesterase-type enzymes, which fall under lipid metabolism. A knowledgeable model can reasonably use the absence of the three specific pathway signatures to select the broad lipid-metabolism category.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The argument relies on elimination of three highly specific pathway assignments whose enzyme families have well-known, distinctive sequence motifs absent from this protein, combined with weak positive features (GxG motifs, overall size/fold) consistent with acyltransferase-type enzymes. This is transferable family-level knowledge about enzyme classification, not a lookup of this specific protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options B, C, and D are very specific pathway assignments tied to well-characterized enzyme families with clear sequence signatures that are absent here. Option A (lipid metabolism) is the broad remaining category and is the correct annotation. No two options are genuinely defensible given the sequence features.


### Important caveats

- The positive identification of 'lipid metabolism' from sequence alone is weaker than the elimination argument; the primary reasoning is the absence of motifs for the three specific distractors rather than a single unambiguous lipid-metabolism motif.
- 'Lipid metabolism' is a very broad UniProt pathway category encompassing many enzyme types; the specific sub-pathway (sulfonolipid biosynthesis) is not distinguishable from the sequence without the database annotation.
- The reviewer evidence confirms the annotation is experimentally supported (PubMed:35414181), but the evaluated model had access only to the raw sequence and the four choices.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The three distractor options (B: carbohydrate degradation, C: terpenoid biosynthesis, D: histidine biosynthesis step 4/9) correspond to enzyme families with well-characterized and distinctive sequence signatures. Carbohydrate-degrading enzymes (glycosidases, cellulases, amylases) possess specific catalytic motifs (e.g., WWDYG for GH families, specific TIM-barrel or β-sandwich folds). Terpenoid biosynthesis enzymes (terpene cyclases, prenyltransferases) display diagnostic DDXXD, NDXXD, or GxGxxG prenyltransferase motifs and characteristic folds. Histidine biosynthesis enzymes (HisA through HisI) each have distinct, well-known domain architectures (e.g., HisA is a TIM-barrel phosphoribosyl-ATP pyrophosphohydrolase; HisB is a phosphatase). The supplied 420-aa sequence lacks all of these signatures. By elimination, lipid metabolism (option A) remains. Additionally, the sequence contains GxG-type motifs (e.g., 'GFGTLGPRGEGTGVHQGVQDEIDVYFSTFAKSMAGIGAFVAGNAKVVDYLKY') and an overall fold consistent with acyltransferase/thioesterase-type enzymes, which fall under lipid metabolism. A knowledgeable model can reasonably use the absence of the three specific pathway signatures to select the broad lipid-metabolism category.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The argument relies on elimination of three highly specific pathway assignments whose enzyme families have well-known, distinctive sequence motifs absent from this protein, combined with weak positive features (GxG motifs, overall size/fold) consistent with acyltransferase-type enzymes. This is transferable family-level knowledge about enzyme classification, not a lookup of this specific protein's annotation."
  },
  "case_id": "pathway_0107",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry (C7M8J6) annotates the pathway as 'Lipid metabolism' with evidence code ECO:0000305 linked to PubMed:35414181 (the capnine sulfonolipid biosynthesis paper). The protein is named 'Cysteate-C-fatty acyltransferase' (EC 2.3.1.-), catalyzing the transfer of a fatty acyl group to cysteate—a lipid biosynthesis reaction. The pathway annotation is directly supported by experimental characterization of the capnine biosynthetic pathway."
  },
  "important_caveats": [
    "The positive identification of 'lipid metabolism' from sequence alone is weaker than the elimination argument; the primary reasoning is the absence of motifs for the three specific distractors rather than a single unambiguous lipid-metabolism motif.",
    "'Lipid metabolism' is a very broad UniProt pathway category encompassing many enzyme types; the specific sub-pathway (sulfonolipid biosynthesis) is not distinguishable from the sequence without the database annotation.",
    "The reviewer evidence confirms the annotation is experimentally supported (PubMed:35414181), but the evaluated model had access only to the raw sequence and the four choices."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options B, C, and D are very specific pathway assignments tied to well-characterized enzyme families with clear sequence signatures that are absent here. Option A (lipid metabolism) is the broad remaining category and is the correct annotation. No two options are genuinely defensible given the sequence features."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0107",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry (C7M8J6) annotates the pathway as 'Lipid metabolism' with evidence code ECO:0000305 linked to PubMed:35414181 (the capnine sulfonolipid biosynthesis paper). The protein is named 'Cysteate-C-fatty acyltransferase' (EC 2.3.1.-), catalyzing the transfer of a fatty acyl group to cysteate—a lipid biosynthesis reaction. The pathway annotation is directly supported by experimental characterization of the capnine biosynthetic pathway.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The three distractor options (B: carbohydrate degradation, C: terpenoid biosynthesis, D: histidine biosynthesis step 4/9) correspond to enzyme families with well-characterized and distinctive sequence signatures. Carbohydrate-degrading enzymes (glycosidases, cellulases, amylases) possess specific catalytic motifs (e.g., WWDYG for GH families, specific TIM-barrel or β-sandwich folds). Terpenoid biosynthesis enzymes (terpene cyclases, prenyltransferases) display diagnostic DDXXD, NDXXD, or GxGxxG prenyltransferase motifs and characteristic folds. Histidine biosynthesis enzymes (HisA through HisI) each have distinct, well-known domain architectures (e.g., HisA is a TIM-barrel phosphoribosyl-ATP pyrophosphohydrolase; HisB is a phosphatase). The supplied 420-aa sequence lacks all of these signatures. By elimination, lipid metabolism (option A) remains. Additionally, the sequence contains GxG-type motifs (e.g., 'GFGTLGPRGEGTGVHQGVQDEIDVYFSTFAKSMAGIGAFVAGNAKVVDYLKY') and an overall fold consistent with acyltransferase/thioesterase-type enzymes, which fall under lipid metabolism. A knowledgeable model can reasonably use the absence of the three specific pathway signatures to select the broad lipid-metabolism category.",
    "missing_item_specific_fact": "",
    "reason": "The argument relies on elimination of three highly specific pathway assignments whose enzyme families have well-known, distinctive sequence motifs absent from this protein, combined with weak positive features (GxG motifs, overall size/fold) consistent with acyltransferase-type enzymes. This is transferable family-level knowledge about enzyme classification, not a lookup of this specific protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options B, C, and D are very specific pathway assignments tied to well-characterized enzyme families with clear sequence signatures that are absent here. Option A (lipid metabolism) is the broad remaining category and is the correct annotation. No two options are genuinely defensible given the sequence features."
  },
  "important_caveats": [
    "The positive identification of 'lipid metabolism' from sequence alone is weaker than the elimination argument; the primary reasoning is the absence of motifs for the three specific distractors rather than a single unambiguous lipid-metabolism motif.",
    "'Lipid metabolism' is a very broad UniProt pathway category encompassing many enzyme types; the specific sub-pathway (sulfonolipid biosynthesis) is not distinguishable from the sequence without the database annotation.",
    "The reviewer evidence confirms the annotation is experimentally supported (PubMed:35414181), but the evaluated model had access only to the raw sequence and the four choices."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "C7M8J6",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "dd4259a5352210ed873f594b99e98145868737457d8a910589f73654ca4ff470",
  "benchmark_sequence_length": 420,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 71,
    "firstPublicDate": "2025-04-09",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2009-10-13",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "b57fb928124b749a162ca2d4352e7e955e837f2a249eb7bd4c46e97dc2bd72a0",
  "current_source_sequence_sha256": "dd4259a5352210ed873f594b99e98145868737457d8a910589f73654ca4ff470",
  "current_source_sequence_length": 420,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 70,
  "selected_historical_version": {
    "accession": "C7M8J6",
    "database": "Swiss-Prot",
    "entryVersion": 70,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "CAPB_CAPOD",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "a7856db74c2257c0ae32918e6ed89fb2b1448ac6527c4a62ff2b4a4bf082737a",
  "selected_historical_source_sequence_sha256": "dd4259a5352210ed873f594b99e98145868737457d8a910589f73654ca4ff470",
  "selected_historical_source_sequence_length": 420,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 70,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C7M8J6.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C7M8J6.json",
  "source_sha256": "b57fb928124b749a162ca2d4352e7e955e837f2a249eb7bd4c46e97dc2bd72a0",
  "retrieved_utc": "2026-11-02T04:27:36.271476+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"C7M8J6\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C7M8J6.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C7M8J6.json",
  "source_sha256": "b57fb928124b749a162ca2d4352e7e955e837f2a249eb7bd4c46e97dc2bd72a0",
  "retrieved_utc": "2026-11-02T04:27:36.271476+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":71,\"firstPublicDate\":\"2025-04-09\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2009-10-13\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C7M8J6.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C7M8J6.json",
  "source_sha256": "b57fb928124b749a162ca2d4352e7e955e837f2a249eb7bd4c46e97dc2bd72a0",
  "retrieved_utc": "2026-11-02T04:27:36.271476+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Bacteroides ochraceus\",\"lineage\":[\"Bacteria\",\"Pseudomonadati\",\"Bacteroidota\",\"Flavobacteriia\",\"Flavobacteriales\",\"Flavobacteriaceae\",\"Capnocytophaga\"],\"scientificName\":\"Capnocytophaga ochracea (strain ATCC 27872 / DSM 7271 / CCUG 9716 / JCM 12966 / NCTC 12371 / SS31 / VPI 2845)\",\"taxonId\":521097}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C7M8J6.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C7M8J6.json",
  "source_sha256": "b57fb928124b749a162ca2d4352e7e955e837f2a249eb7bd4c46e97dc2bd72a0",
  "retrieved_utc": "2026-11-02T04:27:36.271476+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"35414181\",\"source\":\"PubMed\"}],\"value\":\"2.3.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"35414181\",\"source\":\"PubMed\"}],\"value\":\"Cysteate-C-fatty acyltransferase\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C7M8J6.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C7M8J6.json",
  "source_sha256": "b57fb928124b749a162ca2d4352e7e955e837f2a249eb7bd4c46e97dc2bd72a0",
  "retrieved_utc": "2026-11-02T04:27:36.271476+00:00",
  "json_pointer": "/comments/3",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"35414181\",\"source\":\"PubMed\"}],\"value\":\"Lipid metabolism\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/C7M8J6.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/C7M8J6.json",
  "source_sha256": "b57fb928124b749a162ca2d4352e7e955e837f2a249eb7bd4c46e97dc2bd72a0",
  "retrieved_utc": "2026-11-02T04:27:36.271476+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu Y.\",\"Wei Y.\",\"Teh T.M.\",\"Liu D.\",\"Zhou Y.\",\"Zhao S.\",\"Ang E.L.\",\"Zhao H.\",\"Zhang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"35414181\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.biochem.2c00102\"}],\"citationType\":\"journal article\",\"firstPage\":\"2861\",\"id\":\"35414181\",\"journal\":\"Biochemistry\",\"lastPage\":\"2869\",\"publicationDate\":\"2022\",\"title\":\"Identification and Characterization of the Biosynthetic Pathway of the Sulfonolipid Capnine.\",\"volume\":\"61\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"COFACTOR\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C7M8J6?format=txt&versions=70)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/C7M8J6?format=txt&versions=70",
  "source_sha256": "a7856db74c2257c0ae32918e6ed89fb2b1448ac6527c4a62ff2b4a4bf082737a",
  "retrieved_utc": "2026-11-02T04:27:41.947109+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   CAPB_CAPOD              Reviewed;         420 AA.\nAC   C7M8J6;\nDT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.\nDT   13-OCT-2009, sequence version 1.\nDT   28-JAN-2026, entry version 70.\nDE   RecName: Full=Cysteate-C-fatty acyltransferase {ECO:0000303|PubMed:35414181};\nDE            EC=2.3.1.- {ECO:0000269|PubMed:35414181};\nGN   Name=capB {ECO:0000303|PubMed:35414181};\nGN   OrderedLocusNames=Coch_1830 {ECO:0000312|EMBL:ACU93375.1};\nOS   Capnocytophaga ochracea (strain ATCC 27872 / DSM 7271 / CCUG 9716 / JCM\nOS   12966 / NCTC 12371 / SS31 / VPI 2845) (Bacteroides ochraceus).\nOC   Bacteria; Pseudomonadati; Bacteroidota; Flavobacteriia; Flavobacteriales;\nOC   Flavobacteriaceae; Capnocytophaga.\nOX   NCBI_TaxID=521097;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 70,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C7M8J6?format=txt&versions=70)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/C7M8J6?format=txt&versions=70",
  "source_sha256": "a7856db74c2257c0ae32918e6ed89fb2b1448ac6527c4a62ff2b4a4bf082737a",
  "retrieved_utc": "2026-11-02T04:27:41.947109+00:00",
  "source_locator": "lines 29-36",
  "excerpt": "RN   [2]\nRP   FUNCTION, CATALYTIC ACTIVITY, AND COFACTOR.\nRX   PubMed=35414181; DOI=10.1021/acs.biochem.2c00102;\nRA   Liu Y., Wei Y., Teh T.M., Liu D., Zhou Y., Zhao S., Ang E.L., Zhao H.,\nRA   Zhang Y.;\nRT   \"Identification and Characterization of the Biosynthetic Pathway of the\nRT   Sulfonolipid Capnine.\";\nRL   Biochemistry 61:2861-2869(2022).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 70,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/C7M8J6?format=txt&versions=70)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/C7M8J6?format=txt&versions=70",
  "source_sha256": "a7856db74c2257c0ae32918e6ed89fb2b1448ac6527c4a62ff2b4a4bf082737a",
  "retrieved_utc": "2026-11-02T04:27:41.947109+00:00",
  "source_locator": "lines 55-55",
  "excerpt": "CC   -!- PATHWAY: Lipid metabolism. {ECO:0000305|PubMed:35414181}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 70,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 107. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
